Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Harmony Biosciences Holdings (HRMY)

NASDAQ:HRMY

HRMY

Harmony Biosciences Holdings

RESEARCH TOOLSreports

Harmony Biosciences Holdings (HRMY) Ratios

Compare

429 Followers

Harmony Biosciences Holdings Ratios

HRMY's free cash flow for Q4 2025 was $0.72. For the 2025 fiscal year, HRMY's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	3.60	3.60	3.31	2.75	5.07
Quick Ratio	3.58	3.58	3.27	2.72	5.02
Cash Ratio	2.98	2.98	2.59	1.90	3.09
Solvency Ratio	0.46	0.46	0.50	0.44	0.76
Operating Cash Flow Ratio	1.38	1.38	1.26	1.34	1.83
Short-Term Operating Cash Flow Coverage	4.01	4.01	13.53	14.63	72.23
Net Current Asset Value	$ 505.60M	$ 505.60M	$ 239.21M	$ 106.61M	$ 129.25M
Leverage Ratios
Debt-to-Assets Ratio	0.19	0.19	0.18	0.24	0.28
Debt-to-Equity Ratio	0.28	0.28	0.28	0.41	0.48
Debt-to-Capital Ratio	0.22	0.22	0.22	0.29	0.32
Long-Term Debt-to-Capital Ratio	0.15	0.15	0.20	0.28	0.32
Financial Leverage Ratio	1.46	1.46	1.52	1.74	1.67
Debt Service Coverage Ratio	1.92	1.96	5.54	4.57	10.75
Interest Coverage Ratio	14.23	14.23	10.91	8.08	6.39
Debt to Market Cap	0.15	0.11	0.09	0.10	0.06
Interest Debt Per Share	4.41	4.42	3.50	3.65	3.56
Net Debt to EBITDA	-2.04	-2.01	-1.16	-0.53	-0.35
Profitability Margins
Gross Profit Margin	77.16%	77.16%	78.06%	79.17%	80.93%
EBIT Margin	26.03%	26.45%	29.28%	33.87%	28.20%
EBITDA Margin	28.95%	29.37%	32.66%	38.06%	33.54%
Operating Profit Margin	24.00%	24.00%	26.70%	32.99%	27.45%
Pretax Profit Margin	24.76%	24.76%	26.84%	29.79%	23.91%
Net Profit Margin	18.27%	18.27%	20.36%	22.14%	41.44%
Continuous Operations Profit Margin	18.27%	18.27%	20.36%	22.14%	41.44%
Net Income Per EBT	73.79%	73.79%	75.86%	74.31%	173.35%
EBT Per EBIT	103.16%	103.16%	100.51%	90.30%	87.10%
Return on Assets (ROA)	12.48%	12.48%	14.56%	15.88%	26.93%
Return on Equity (ROE)	19.84%	18.24%	22.07%	27.59%	45.05%
Return on Capital Employed (ROCE)	20.45%	20.45%	23.16%	29.65%	20.20%
Return on Invested Capital (ROIC)	13.90%	13.90%	17.20%	21.53%	20.13%
Return on Tangible Assets	13.42%	13.42%	16.42%	19.11%	35.38%
Earnings Yield	9.98%	7.38%	7.43%	6.71%	5.57%
Efficiency Ratios
Receivables Turnover	8.97	8.97	8.61	7.85	8.00
Payables Turnover	11.21	11.21	11.41	6.84	22.05
Inventory Turnover	37.02	37.02	21.79	22.61	19.43
Fixed Asset Turnover	162.51	162.51	211.52	1.57K	764.14
Asset Turnover	0.68	0.68	0.72	0.72	0.65
Working Capital Turnover Ratio	1.37	1.64	2.07	1.91	1.59
Cash Conversion Cycle	17.98	17.98	27.17	9.26	47.87
Days of Sales Outstanding	40.68	40.68	42.40	46.49	45.63
Days of Inventory Outstanding	9.86	9.86	16.75	16.15	18.79
Days of Payables Outstanding	32.56	32.56	31.99	53.38	16.55
Operating Cycle	50.54	50.54	59.16	62.64	64.42
Cash Flow Ratios
Operating Cash Flow Per Share	6.04	6.06	3.86	3.69	2.44
Free Cash Flow Per Share	6.04	6.05	3.84	3.68	2.44
CapEx Per Share	<0.01	<0.01	0.02	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	0.99	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	1.12K	1.12K	190.65	703.16	839.92
Capital Expenditure Coverage Ratio	1.12K	1.12K	190.65	703.16	839.92
Operating Cash Flow Coverage Ratio	1.45	1.45	1.21	1.13	0.75
Operating Cash Flow to Sales Ratio	0.40	0.40	0.31	0.38	0.33
Free Cash Flow Yield	21.79%	16.17%	11.17%	11.40%	4.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	10.02	13.56	13.45	14.91	17.97
Price-to-Sales (P/S) Ratio	1.84	2.48	2.74	3.30	7.45
Price-to-Book (P/B) Ratio	1.83	2.47	2.97	4.11	8.09
Price-to-Free Cash Flow (P/FCF) Ratio	4.59	6.18	8.95	8.77	22.60
Price-to-Operating Cash Flow Ratio	4.57	6.18	8.90	8.76	22.57
Price-to-Earnings Growth (PEG) Ratio	-0.68	1.74	0.75	-0.51	0.04
Price-to-Fair Value	1.83	2.47	2.97	4.11	8.09
Enterprise Value Multiple	4.31	6.42	7.22	8.14	21.85
Enterprise Value	1.08B	1.64B	1.69B	1.80B	3.21B
EV to EBITDA	4.31	6.42	7.22	8.14	21.85
EV to Sales	1.25	1.89	2.36	3.10	7.33
EV to Free Cash Flow	3.11	4.71	7.71	8.23	22.23
EV to Operating Cash Flow	3.11	4.71	7.67	8.22	22.21
Tangible Book Value Per Share	13.55	13.58	9.60	5.55	4.09
Shareholders’ Equity Per Share	15.10	15.14	11.59	7.85	6.81
Tax and Other Ratios
Effective Tax Rate	0.26	0.26	0.24	0.26	-0.73
Revenue Per Share	15.07	15.11	12.56	9.79	7.40
Net Income Per Share	2.75	2.76	2.56	2.17	3.07
Tax Burden	0.74	0.74	0.76	0.74	1.73
Interest Burden	0.95	0.94	0.92	0.88	0.85
Research & Development to Revenue	0.22	0.22	0.20	0.13	0.16
SG&A to Revenue	0.18	0.18	0.15	0.16	0.19
Stock-Based Compensation to Revenue	0.05	0.05	0.06	0.05	0.06
Income Quality	2.19	2.19	1.51	1.70	0.80

Currency in USD